Please join us for an inside look at how the latest legal and regulatory developments in EU law will affect companies operating in the life sciences space. We will bring together senior and former members of the European Commission, the European Medicines Agency (EMA), the Dutch Medicines Evaluation Board, the Swiss Agency for Therapeutic Products (Swissmedic), the U.S. Food & Drug Administration (FDA) as well as representatives from the regulatory and business community to address key issues of relevance to pharmaceutical and medical device companies in 2019.
Panel discussions will cover clinical trials, pharmacovigilance, orphan drugs, new pathways to marketing authorizations, falsified medicines, pharmaceutical incentives, transparency on pricing, pharmacy compounding, advanced therapy medicinal products (ATMPs), fees, off-label use, biosimilars, medical devices and Brexit among other topics.
This year’s keynote address will be presented by the European Commission’s Head of Unit to the Directorate General for Health and Food Safety (DG SANTE), Olga Solomon.
Amgen Anne de la Fortelle | Astellas Robert Washington | Dutch Medicines Evaluation Board Diederick Slijkerman | EUCOPE Alexander Natz | European Commission Salvatore D’Acunto • Agnès Mathieu-Mendes • Olga Solomon | GIRP (European Healthcare Distribution Association) Monika Derecque-Pois | Johnson & Johnson Joyce ter Heerdt | MedTechEurope Oliver Bisazza • Petra Zoellner | Norgine Victorio Hünerberg Coli | PwC David Andersen | Sidley Andreas Balsiger Betts • Georgia Gavriilidou • Olivier Goarnisson • Maurits Lugard • Maarten Meulenbelt • Anna Pavlou • Josefine Sommer • Rebecca Wood
Click here to view the agenda.
For more information, please contact Cristina Menéndez Ruiz at +32 2 504 6453 or firstname.lastname@example.org.
The event is open to in-house counsel, regulators and regulatory personnel at pharmaceutical and medical devices companies. There is no registration fee to attend this event. Due to space limitations for this event, registrations will be reviewed and confirmed by email. For more information, please contact Cristina Menendez Ruiz at +32 2 504 64 53 or email@example.com.